Trial Profile
Normalization of T cell receptor repertoire diversity in patients with advanced colorectal cancer who responded to chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2011
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 20 Apr 2011 New trial record